{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae BUP/TCA Single/Multi-Panel Drug Screen Dip Card/Cup/Cassette Tests",
        "Chemtrue\u00ae Multi-Panel Drug Screen Dip Card Tests",
        "Chemtrue\u00ae Multi-Panel Drug Screen Dip Card with OPI 2000 Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K142396",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "LFG",
        "DKZ",
        "DIO",
        "LAF",
        "LCM",
        "LDJ",
        "JXM",
        "DIS",
        "DJC",
        "DJR",
        "DNK"
    ],
    "Summary Letter Date": "August 27, 2014",
    "Summary Letter Received Date": "August 28, 2014",
    "Submission Date": "October 8, 2014",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3910",
        "21CFR862.3100",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3870",
        "21CFR862.3170",
        "21CFR862.3150",
        "21CFR862.3620",
        "21CFR862.3640"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Tricyclic Antidepressants test system",
        "Amphetamine Test System",
        "Cocaine and metabolites Test System",
        "Methamphetamine Test System",
        "Cannabinoids Test System",
        "Benzodiazepines Test System",
        "Barbiturates Test System",
        "Methadone Test System",
        "Morphine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Tricyclic Antidepressants",
        "Amphetamine",
        "Cocaine",
        "Methamphetamine",
        "Morphine",
        "Opiates",
        "Phencyclidine",
        "Marijuana",
        "Benzodiazepines",
        "Barbiturates",
        "Ecstasy",
        "Methadone",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Dip Card",
        "Cup",
        "Cassette"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow assay"
    ],
    "Submission Type(s)": [
        "Dip Card",
        "Cup",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue BUP/TCA Single/Multi-Panel Drug Screen Dip Card/Cup/Cassette Tests for qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "Intended for the qualitative detection of Buprenorphine, Tricyclic Antidepressants, and other drugs of abuse in human urine by rapid lateral flow immunoassay in prescription and over-the-counter settings; provides preliminary results and requires confirmatory testing.",
    "fda_folder": "Toxicology"
}